AQUA

:   absolute quantification of proteins

EtEP

:   equimolarity through equalizer peptide

iBAQ

:   intensity‐based absolute quantification

QconCAT

:   quantification concatamer

1. Characteristics of macromolecular protein complexes: Composition, stoichiometry/copy number, topology and dynamics {#pmic8038-sec-0010}
=====================================================================================================================

In the crowded environment of the cell, proteins are permanently engaged in interactions with other biomolecules such as other proteins, DNA, RNA, or lipids. Cellular function can rarely be attributed to isolated molecules; instead, it is most often affected by functional modules. These complexes range in size and complexity from simple homodimeric enzymes up to complex macromolecular machines such as the ribosome. Macromolecular complexes can be investigated at different levels (Fig. [1](#pmic8038-fig-0001){ref-type="fig"}): (A) composition, (B) stoichiometry, (C) copy number, (D) topology, and (E) dynamics.

![Different layers of macromolecular complex characteristics. Complex composition (A) encompasses the list of complex constituents. Complex stoichiometry (B) defines the abundance of constituents relative to each other, while the copy number (C) quantifies the absolute number of constituents per complex. Complex topology (D) describes the spatial setup of the constituents in the complex. Complex dynamics (E) represent the alterations in composition, stoichiometry, and topology over time.](PMIC-15-862-g001){#pmic8038-fig-0001}

Qualitatively, complexes involving proteins can be characterized by (A) their composition, that is the qualitative identification of their constituents. Compositions of protein complexes are most frequently determined through a combination of affinity‐based purification, using a binding partner of interest (bait), and shotgun MS analysis of interaction partners. Pioneer work on large‐scale studies of protein--protein interactions, for example in yeast [1](#pmic8038-bib-0001){ref-type="ref"}, [2](#pmic8038-bib-0002){ref-type="ref"}, has revealed extensive interaction networks, indicating that the majority of cellular functions are indeed affected through macromolecular complexes [3](#pmic8038-bib-0003){ref-type="ref"}.

The complex\'s second qualitative property is its topology (D), that is the shape and relative spatial arrangement of its constituents (Fig. [1](#pmic8038-fig-0001){ref-type="fig"}D). Traditionally, topology is studied by methods that directly provide spatial information, such as NMR [4](#pmic8038-bib-0004){ref-type="ref"}, X‐ray crystallography [5](#pmic8038-bib-0005){ref-type="ref"}, electron cryomicroscopy [6](#pmic8038-bib-0006){ref-type="ref"} or electron tomography [7](#pmic8038-bib-0007){ref-type="ref"}. More recently, MS‐based methods such as MS of intact protein complexes, protein--protein cross‐linking, radical footprinting, or H/D exchange MS have substantially contributed to our knowledge of protein complex topology (reviewed in [8](#pmic8038-bib-0008){ref-type="ref"}, [9](#pmic8038-bib-0009){ref-type="ref"}, [10](#pmic8038-bib-0010){ref-type="ref"}).

In contrast to these qualitative properties, the relative stoichiometry (Fig. [1](#pmic8038-fig-0001){ref-type="fig"}B), that is the ratio of the complex\'s constituents, and the closely related absolute number (C) of constituent copies, both require analysis at a quantitative level. Information about copy numbers (Fig. [1](#pmic8038-fig-0001){ref-type="fig"}C) of the various components in a complex supersedes the information about relative stoichiometry, which is plainly illustrated by the case of urease from *Helicobacter pylori*. Urease is composed of α and β subunits, which form a dodecameric suprastructure (α β)~12~ [11](#pmic8038-bib-0011){ref-type="ref"}. Methods that aim to determine the stoichiometry will show a 1:1 relative stoichiometry, but this ignores the oligomeric nature of the complex. To obtain information on copy numbers in a complex, additional complementary information about its topology (Fig. [1](#pmic8038-fig-0001){ref-type="fig"}D), molecular weight, or geometric size has to be available.

Finally, complex dynamics (Fig. [1](#pmic8038-fig-0001){ref-type="fig"}E) describe changes of the above properties (A--D) over time; these can often be attributed to cellular function. Such changes depend on the expression levels, the compartmentation, and (post‐translational) modifications of its components, all of which may vary during growth, during the cell cycle, or in response to extracellular stimuli. As an example, Ori et al. used targeted peptide‐based MS to show that the stoichiometry of proteins in the human nuclear pore complex displays significant variation between different cancer‐associated cell lines, indicating that even quantitative complex properties are adjustable for function [12](#pmic8038-bib-0012){ref-type="ref"}.

To the best of our knowledge, MS is the only technology that can contribute to the investigation of protein(--ligand) complexes at all these levels. This review focuses on the less frequently described MS‐based approaches for the analysis of protein complex stoichiometry and of copy numbers in isolated complexes, namely the so‐called "bottom up" approach in which the stoichiometry of protein complexes is investigated at the peptide level after enzymatic digestion. The merits and challenges of the peptide‐based approach will be discussed against the backdrop of alternative methods.

2. General remarks concerning the purification and study of intact protein complexes {#pmic8038-sec-0020}
====================================================================================

In most cases, the stoichiometries of complexes assembled in vivo are studied in vitro (or ex vivo). Apart from mass spectrometric approaches, a variety of methods have been established to study stoichiometry (Table [1](#pmic8038-tbl-0001){ref-type="table-wrap"}) [4](#pmic8038-bib-0004){ref-type="ref"}, [5](#pmic8038-bib-0005){ref-type="ref"}, [6](#pmic8038-bib-0006){ref-type="ref"}, [7](#pmic8038-bib-0007){ref-type="ref"}, [13](#pmic8038-bib-0013){ref-type="ref"}, [14](#pmic8038-bib-0014){ref-type="ref"}, [15](#pmic8038-bib-0015){ref-type="ref"}, [16](#pmic8038-bib-0016){ref-type="ref"}, [17](#pmic8038-bib-0017){ref-type="ref"}, [18](#pmic8038-bib-0018){ref-type="ref"}, [19](#pmic8038-bib-0019){ref-type="ref"}, [20](#pmic8038-bib-0020){ref-type="ref"}, [21](#pmic8038-bib-0021){ref-type="ref"}, [22](#pmic8038-bib-0022){ref-type="ref"}, [23](#pmic8038-bib-0023){ref-type="ref"}, [24](#pmic8038-bib-0024){ref-type="ref"}, [25](#pmic8038-bib-0025){ref-type="ref"}. Apart from their different requirements---such as complex purity, stability, availability, etc.---these methods often provide additional information on topology, binding affinities, etc. Thus, complex stoichiometry is often part of an information package that can be gained by a particular method.

###### 

Classical methods for stoichiometry determination

  Class of method       Method                                                                                                             Source of complex          References
  --------------------- ------------------------------------------------------------------------------------------------------------------ -------------------------- ----------------------------------------------------------------
  Biophysical methods   Isothermal titration calorimetry (ITC)                                                                             In vitro                   Feig [13](#pmic8038-bib-0013){ref-type="ref"}
                        Static and dynamic light‐scattering (SEC‐MALS)                                                                     Ex vivo/in vitro           Some [14](#pmic8038-bib-0014){ref-type="ref"}
                        Surface plasmon resonance (SPR)                                                                                    In vitro                   Day et al. [15](#pmic8038-bib-0015){ref-type="ref"}
                        Analytical ultracentrifugation                                                                                     Ex vivo/in vitro           Padrick and Brautigam [16](#pmic8038-bib-0016){ref-type="ref"}
                        Single‐molecule fluorescence correlation spectroscopy (FCS)                                                        In vivo/ex vivo/in vitro   Bulseco and Wolf [23](#pmic8038-bib-0023){ref-type="ref"}
                        Single‐molecule fluorescence intensity distribution analysis (FIDA), fluorescence fluctuation spectroscopy (FFS)   In vivo/ex vivo/in vitro   Saffarian et al. [17](#pmic8038-bib-0017){ref-type="ref"}
                        Single‐molecule TIRF bleaching                                                                                     In vivo/ex vivo/in vitro   Nakajo et al. [18](#pmic8038-bib-0018){ref-type="ref"}
  Biochemical methods   Native gel electrophoresis + densitometry                                                                          Ex vivo/in vitro           Wittig et al. [19](#pmic8038-bib-0019){ref-type="ref"}
                        Radiometric quantification                                                                                         Ex vivo/in vitro           Mogridge et al. [24](#pmic8038-bib-0024){ref-type="ref"}
                        Size‐exclusion chromatography (SEC)                                                                                Ex vivo/in vitro           Winzor et al. [25](#pmic8038-bib-0025){ref-type="ref"}
                        Western blot                                                                                                       Ex vivo/in vitro           Diaconu et al. [20](#pmic8038-bib-0020){ref-type="ref"}
  Structural methods    NMR                                                                                                                Ex vivo/in vitro           Cavanagh et al. [4](#pmic8038-bib-0004){ref-type="ref"}
                        X‐ray crystallography                                                                                              Ex vivo/in vitro           McPherson [5](#pmic8038-bib-0005){ref-type="ref"}
                        Cryo electron microscopy                                                                                           Ex vivo/in vitro           Orlova and Saibil [6](#pmic8038-bib-0006){ref-type="ref"}
                        Atomic force microscopy (AFM)                                                                                      Ex vivo/in vitro           Barrera et al. [21](#pmic8038-bib-0021){ref-type="ref"}
                        Scanning transmission electron microscopy (STEM)                                                                   Ex vivo/in vitro           Müller et al. [22](#pmic8038-bib-0022){ref-type="ref"}
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The quantitative nature of a stoichiometry puts high demands on the preservation of the complex\'s structural and functional integrity upon cell lysis and during subsequent purification. If complex integrity is not ensured and confirmed, values for the stoichiometries determined cannot be regarded as robust.

When protein complexes are purified, their thermodynamic stability (which was essential for their assembly in vivo) becomes less relevant than their kinetic inertness. The protocols used for cell lysis and purification often embody huge changes to the physiological milieu under which the complex was formed with regard to solvents, pH, ionic strength, and temperature. In addition, most purification protocols include dilution steps, which shift all complex‐binding equilibria toward the free components. Under these nonequilibrium conditions, complexes will start to dissociate, and their integrity depends on their dissociation rates, the duration of the purification, and the experimental conditions, for example temperature. Usually, a compromise has to be made between the complexes' purity and the preservation of its stoichiometry. Consequently, the requirements for purification procedures for stoichiometry studies differ from those for interactome studies (as reviewed in [26](#pmic8038-bib-0026){ref-type="ref"}) and should be "fast, cold, and concentrated" [27](#pmic8038-bib-0027){ref-type="ref"}, [28](#pmic8038-bib-0028){ref-type="ref"}. For this reason, the purification procedure has to be adapted to each individual target complex and its kinetic properties. Classical multistep purification procedures (centrifugation, etc.) are fast enough for stable nanomachines (e.g. the ribosome [29](#pmic8038-bib-0029){ref-type="ref"}) to retain their integrity. However, more transient complexes require faster purification strategies, and for these a large repertoire of antibody‐ or tag‐based affinity purification procedures has been established [30](#pmic8038-bib-0030){ref-type="ref"}.

Isolation of complexes should go hand in hand with the investigation of their preservation and functional integrity. Besides biochemical methods, MS‐based approaches have been developed to distinguish between stable and dynamic components. Isotope‐labeled preparations with tagged bait protein are mixed with differently labeled nontagged preparations. After purification and digestion, only dynamic---that is exchangeable---components exhibit mixed labeling and can thus be differentiated from stable components [31](#pmic8038-bib-0031){ref-type="ref"}, [32](#pmic8038-bib-0032){ref-type="ref"}, [33](#pmic8038-bib-0033){ref-type="ref"}. Highly dynamic complexes, which undergo full equilibration of their subunits in the time window of purification, can also be studied in a time‐resolved fashion (tc‐PAM SILAC or MAP (mixing after purification)‐SILAC).

When complexes are known to be transient, different approaches can be envisaged for their stabilization. The physicochemical environment can be optimized by high‐throughput screens for complex preservation [34](#pmic8038-bib-0034){ref-type="ref"}. Functional complexes can be trapped by specific inhibitors, for example the kirromycin‐stalled EF‐Tu--tRNA--ribosome complex [35](#pmic8038-bib-0035){ref-type="ref"}, or complex assembly can be stopped by deletion of essential assembly factors (reviewed in [36](#pmic8038-bib-0036){ref-type="ref"}). In addition, cross‐linking can be used to "freeze" assembled protein complexes for further analysis [37](#pmic8038-bib-0037){ref-type="ref"}.

3. Determination of complex stoichiometry by applying MS of intact protein complexes {#pmic8038-sec-0030}
====================================================================================

In general, MS can be applied to the study of protein complexes in two ways: either entire intact macromolecular assemblies are analyzed, hereafter termed "MS of intact complexes," or complex properties such as stoichiometry are investigated on the peptide level after enzymatic digestion, hereafter termed "peptide‐based stoichiometry determination" (see below). These MS methods, which are otherwise highly orthogonal, each overcome a variety of limitations of non‐MS approaches. Both require relatively small amounts of complex (pmol or less), and both allow the study of very large macromolecular assemblies where protein stoichiometries/copy numbers and topology cannot easily be investigated by classical structure‐resolving methods such as NMR or X‐ray crystallography. In addition, neither method is hampered by dynamic regions of the complex\'s components, such as flexible termini of proteins or completely unstructured proteins, which impede topology determination by, for example, cryo EM or X‐ray crystallography. Notably, when applied to the same macromolecular complex (e.g. the prokaryotic 70S ribosome), both MS methods lead to stoichiometries that are in good agreement with non‐MS‐based methods [38](#pmic8038-bib-0038){ref-type="ref"}, [39](#pmic8038-bib-0039){ref-type="ref"}.

MS of intact protein complexes is often considered the gold standard for the investigation of complex structures. It allows the accurate measurement of the intact masses of a complex or its subunits. If the protein composition is known, then stoichiometry and copy number can be deduced directly from this combined information.

Studying intact macromolecular complexes by MS was made possible by the finding that "soft" ionization methods such as ESI [40](#pmic8038-bib-0040){ref-type="ref"} or MALDI do not necessarily disrupt noncovalent interactions when performed under controlled conditions. Of the two, MALDI is the more tolerant to higher salt concentrations and produces spectra that are easier to interpret owing to the formation of largely singly charged quasi‐molecular ions [37](#pmic8038-bib-0037){ref-type="ref"}. However, MALDI suffers from some limitations, because the incorporation of a protein complex into the solid MALDI matrix can disrupt noncovalent interactions. In addition, nonspecific protein/protein adducts are often formed, either during matrix crystallization or in the plume directly after laser irradiation. While these limitations can be circumvented by chemical cross‐linking of proteins in a complex [37](#pmic8038-bib-0037){ref-type="ref"}, they have still prevented widespread use of this approach. ESI on the other hand is the milder ionization method of the two and nowadays dominates the field of MS of protein(--ligand) complexes [41](#pmic8038-bib-0041){ref-type="ref"}, [42](#pmic8038-bib-0042){ref-type="ref"}. Successful transfer of intact complexes to the gas phase in ESI‐MS depends on the nature of their interactions: Electrostatic interactions and hydrogen bonds will be strengthened upon evaporation of the solvent, while hydrophobic interactions are loosened [43](#pmic8038-bib-0043){ref-type="ref"}. Because basic residues are often involved in protein--protein interaction [44](#pmic8038-bib-0044){ref-type="ref"}, and because the addition of a protein to a complex leads to a greater relative increase in the complex\'s molecular weight than in its surface area, only a relatively small percentage of the basic residues present in intact protein complexes is exposed at the complex\'s surface. The result is a relatively low net charge and hence high *m*/*z* values compared with, for example, single proteins under denaturing conditions. This necessitates the use of mass analyzers with a wide *m*/*z* range (up to 30 000) and relatively high mass resolution. Consequently, orthogonal TOF mass analyzers have become a standard platform for native MS. Recent improvements in the technology of Orbitrap mass analyzers have made these suitable as well [45](#pmic8038-bib-0045){ref-type="ref"}, [46](#pmic8038-bib-0046){ref-type="ref"}. Besides the choice of mass analyzer, optimization of the ESI**‐**MS interface and ion‐transfer regions is also necessary for the successful analysis of noncovalent macromolecular complexes. Of especial value is the use of increased pressure in the ESI--MS interface region to improve intact transmission of the complexes in the gas phase by collisional cooling and focusing [47](#pmic8038-bib-0047){ref-type="ref"}, [48](#pmic8038-bib-0048){ref-type="ref"}, [49](#pmic8038-bib-0049){ref-type="ref"}.

Information about complex stoichiometry is derived from intact protein MS by combining (i) measurements of the absolute mass of the intact complex, (ii) determinations of its composition, usually after tryptic digestion, and (iii) measurement of the masses of the individual subunits (reviewed in [50](#pmic8038-bib-0050){ref-type="ref"}). The intact mass is measured under nondenaturing conditions by using an ESI‐compatible volatile buffer system (Fig. [2](#pmic8038-fig-0002){ref-type="fig"}). The zero--charge mass of the native complex is obtained from the resulting charge state series by deconvolution. In the case of heterologous proteins, the masses of the subunits can often be derived from databases. However, protein degradation or truncations of heterologous proteins can hamper the mass assignment. For in vivo assembled complexes, a significant degree of PTM or N‐terminal processing can further impede an unambiguous subunit assignment. Here, denaturation of the complexes and subsequent ESI‐MS analysis allow the subunit assignment to be made in a single step (Fig. [2](#pmic8038-fig-0002){ref-type="fig"}). Additionally, complexes can be partially disassembled in the gas phase by MS/MS using CID. Collisions with gas molecules first lead to dissociation of water or counterions, followed by structural distortions of the protein assembly, and finally to unfolding and ejection of single peripheral subunits from the macromolecular assembly (reviewed in [51](#pmic8038-bib-0051){ref-type="ref"}, [52](#pmic8038-bib-0052){ref-type="ref"}). The CID pathway is usually asymmetric and yields highly charged monomers and a stripped complex of lower charge. Different dissociation pathways operating in parallel can lead to the formation of different stripped complexes in the same experiment. For complexes with few subunits or high symmetry, the determination of the stoichiometry is straightforward. In the case of highly complex dissociation patterns, an ion mobility separation stage in the mass spectrometer (IM‐MS) can help to simplify correct assignment of charge state series by separating complexes and complex subunits according to their collisional cross‐sections (reviewed in [53](#pmic8038-bib-0053){ref-type="ref"}). Improved software algorithms for the deconvolution and interpretation of native ESI mass spectra of complexes have further extended the range of applications, making possible the analysis of the stoichiometry and topology of eight subunits in the 29‐subunit assembly of the rotary ATP synthase from *Enterococcus hirae* [54](#pmic8038-bib-0054){ref-type="ref"}.

![Workflows for MS‐based stoichiometry determination. In the case of the peptide‐based methods, the isolated ribosomes are proteolyzed. Isotopolog proxy peptides that are used for normalization of the endogenous peptides coelute when separated by RP chromatography. Endogenous and AQUA peptide are sprayed into a triple quadrupole mass spectrometer. The first quadrupole filters peptides having the correct *m/z* ratio while blocking all other peptides. Peptides that passed the first quadrupole are fragmented in the collision cell. Fragments of the desired *m/z* ratio are selected in the third quadrupole. Since triple quadrupole mass spectrometers can rapidly vary the settings of both quadrupoles (transitions), fragments of the AQUA peptide and the endogenous peptide coelute and can be quantified relatively to each other. From these ratios, the complex stoichiometry can be readily deduced. For protein‐based MS, isolated ribosomes are sprayed into a modified high‐mass quadrupole TOF (QTOF) spectrometer [48](#pmic8038-bib-0048){ref-type="ref"}. In a first step, the intact mass of the ribosomes is determined. Then, ribosomes are dissociated in the collision cell and different ribosomal stalk complexes are formed. Knowing the overall mass and the mass of different ribosomal subcomplexes, the L12:L10 stoichiometry can be extracted.](PMIC-15-862-g002){#pmic8038-fig-0002}

In addition to the determination of protein stoichiometries and protein copy numbers, MS of intact protein complexes can assist in the deduction of complex topologies including assessing direct interactions between complex subunits [55](#pmic8038-bib-0055){ref-type="ref"}, [56](#pmic8038-bib-0056){ref-type="ref"}, [57](#pmic8038-bib-0057){ref-type="ref"}, can measure ligand binding affinities [58](#pmic8038-bib-0058){ref-type="ref"} or enzymatic turnover rates [40](#pmic8038-bib-0040){ref-type="ref"} and even the polydipersity, that is the different oligomeric states of a protein complex in the sample [59](#pmic8038-bib-0059){ref-type="ref"}, and has been used to study protein folding [60](#pmic8038-bib-0060){ref-type="ref"}. Nonetheless, the analysis of complex stoichiometry by MS at the level of intact proteins comes with some limitations: (i) The complex under investigation must be stable in buffer systems that are compatible with ESI, for example ammonium acetate solutions at pH values within its buffer ranges [61](#pmic8038-bib-0061){ref-type="ref"}. (ii) Complexes need to be highly purified to avoid ion suppression or signal overlay by other analytes in the sample, and (iii) they need to be highly concentrated (in the micromolar range) in order to force the binding equilibrium toward the intact complex. (iv) In addition, strong ion currents for the complexes' quasimolecular ions are required because of the distribution of the signal onto multiple charge states, the reduced transmission of MS ion optics at higher *m*/*z*, and the inherently lower sensitivity of MCP detectors typically used in TOF‐MS instruments for higher mass analytes. Finally, (v) the interface regions of commercially available mass spectrometers are usually not suited for efficient cooling and focusing of noncovalently bound assemblies, and they require modification of, for example, the pressure regime (see above). Consequently, the mass spectrometers used for this type of analyses are still, with the exception of a recently introduced Orbitrap instrument [45](#pmic8038-bib-0045){ref-type="ref"}, heavily modified at the hardware level [48](#pmic8038-bib-0048){ref-type="ref"}, [62](#pmic8038-bib-0062){ref-type="ref"}, which has hampered a wider adoption of this approach in the field yet.

4. Determination of complex stoichiometry by application of peptide‐based MS {#pmic8038-sec-0040}
============================================================================

Peptide‐based MS used for investigation of protein stoichiometries is inherently more sensitive; it does not require high sample purity and allows the measurement of several experimental values per protein, leading to high statistical confidence. It is generally compatible with front--end separation devices hyphenated to the ESI mass spectrometer, allowing the analysis of complex constituents even in the presence of an excess of other biomolecules. While this makes peptide‐based MS much more closely compatible with the analysis of complexes isolated and purified from in vivo samples, it is important to note that it has its own drawbacks, limitations and pitfalls, which will be discussed later in this review.

Peptide‐based stoichiometry determinations rely on the measurement of the constituent proteins' concentrations in a complex, rather than on the measurement of its mass. These are obtained by quantification of representative sets of peptides (proxy peptides) for all subunits after enzymatic proteolysis. Complex stoichiometries are derived from the integrated MS signal intensities of these proxy peptides, rather than from molecular weight differences (as for intact complex MS analysis). Importantly, MS signal intensities of peptides strongly depend on their physicochemical properties and, in consequence, on their ionization efficiencies. This makes a direct, precise quantification impossible and necessitates the use of quantified standards for external or internal calibration, for example by spiking with isotopically labeled reference peptides of the same sequence at known concentrations in the so‐called absolute quantification of proteins (AQUA) approach [63](#pmic8038-bib-0063){ref-type="ref"}. Since the endogenous peptides and isotopically labeled reference peptides have the same properties, their intensities are directly comparable. The use of reference proxy peptides that resemble the endogenous peptides necessitates the a priori determination of the protein composition, either by survey LC‐MS/MS analysis or by available database entries. The important aspects of how reference peptides are chosen and can be generated are discussed in a later section of this review.

The MS intensities between reference peptides and endogenous peptides can be measured by various means. The gold standard is clearly SRM performed on triple quadrupole instruments (Fig. [2](#pmic8038-fig-0002){ref-type="fig"}). Briefly, a single SRM experiment---or SRM transition---employs two‐stage quadrupole filtering for determining the *m*/*z* of the intact peptide precursor before CID, and for determining the *m*/*z* of a selected fragment ion after CID, in a quadrupole collision cell. Fragments reaching the detector are recorded over time. To make the protein quantification more robust toward confounding factors---such as integration errors caused by coeluting contaminants or problems with the quantification and handling of individual reference peptides---usually three to four transitions, corresponding to three to four fragments, are monitored per peptide, and two to three peptides per protein. The corresponding transitions are measured in a sequential manner in each experimental cycle. Quantification is achieved by comparing the peak areas recorded for the transitions of endogenous and the reference peptides. Because the reference peptides were spiked into the samples in known amounts, the integrated signal for the peptides can readily be normalized to yield peptide and thus protein concentrations. From the ratio of protein concentrations, the complex stoichiometries can easily be determined. Using this peptide‐based quantification, the stoichiometries of very different complexes from different organisms using different sources of reference peptides have been quantified (Table [2](#pmic8038-tbl-0002){ref-type="table-wrap"}) [38](#pmic8038-bib-0038){ref-type="ref"}, [64](#pmic8038-bib-0064){ref-type="ref"}, [65](#pmic8038-bib-0065){ref-type="ref"}, [66](#pmic8038-bib-0066){ref-type="ref"}, [67](#pmic8038-bib-0067){ref-type="ref"}, [68](#pmic8038-bib-0068){ref-type="ref"}, [69](#pmic8038-bib-0069){ref-type="ref"}, [70](#pmic8038-bib-0070){ref-type="ref"}, [71](#pmic8038-bib-0071){ref-type="ref"}, [72](#pmic8038-bib-0072){ref-type="ref"}, [73](#pmic8038-bib-0073){ref-type="ref"}, [74](#pmic8038-bib-0074){ref-type="ref"}, [75](#pmic8038-bib-0075){ref-type="ref"}, [76](#pmic8038-bib-0076){ref-type="ref"}, [77](#pmic8038-bib-0077){ref-type="ref"}, [78](#pmic8038-bib-0078){ref-type="ref"}.

###### 

Complex stoichiometries determined by peptide‐based MS

  Complex                             Organism                          Composition (stoichiometry)                                             Purification                           Reference peptide        References
  ----------------------------------- --------------------------------- ----------------------------------------------------------------------- -------------------------------------- ------------------------ -------------------------------------------------------------
  hPrp19/CDc5L spliceosomal complex   Human                             Prp19:CD5L/SPF27/PRL1/CTNBL1 (4:2:1:1:1)                                Immunoadsorption                       AQUA                     Schmidt et al. [64](#pmic8038-bib-0064){ref-type="ref"}
  Cullin‐ring Ubiquitin ligase        Human                             \>10 Subunits (diverse)                                                 Immunoprecipitation                    AQUA                     Bennett et al. [65](#pmic8038-bib-0065){ref-type="ref"}
  Ribosomal stalk                     *E. coli A. platensis*            L10/L12 (1:4 and 1:8)                                                   Sucrose gradients                      AQUA                     Davydov et al. [38](#pmic8038-bib-0038){ref-type="ref"}
  Protein phosphatase 2A network      Human                             8 Subunits (1:1 to 1:20)                                                Affinity purification (SH‐quant) tag   AQUA                     Wepf et al. [66](#pmic8038-bib-0066){ref-type="ref"}
  CD95 death‐inducing signaling       Human                             FADD/procaspase‐8/c‐FLIP/procaspase‐10 (1:2:0.1:0.3)                    Immunoprecipitation                    AQUA                     Warnken et al. [67](#pmic8038-bib-0067){ref-type="ref"}
  Adenovirus                          Human                             \>10 Subunits (diverse)                                                 Cesium gradients                       AQUA                     Benevento et al. [68](#pmic8038-bib-0068){ref-type="ref"}
  Proteasome                          *S. cerevisiae*                   Rpn10/Rpt1/Rpn13 (2:2:1)                                                Immunopurification                     AQUA                     Berko et al. [69](#pmic8038-bib-0069){ref-type="ref"}
  U1 snRNP                            Human                             U1--70K/U1‐C/U1A/SmB/SmD1/SmD2/SmD3/SmE/SmF/SmG (1:1:1:1:1:1:1:1:1:1)   Immunopurification + chromatography    ICPL                     Hochleitner et al. [70](#pmic8038-bib-0070){ref-type="ref"}
  Cohesin core complex                Human                             SMC1/SMC3/RAD21/SA1/2 (1:1:1:1)                                         Immunoadsorption                       EtEP                     Holzmann et al. [71](#pmic8038-bib-0071){ref-type="ref"}
  MP1/p14 complex                     Murine (expressed in *E. coli*)   MP1/p14 (1:1)                                                           Affinity purification (His tag)        EtEP                     Holzmann et al. [72](#pmic8038-bib-0072){ref-type="ref"}
  Cohesin core complex                Human                             \>10 Subunits (diverse)                                                 Immunoprecipitation                    qConCAT                  Ding et al. [73](#pmic8038-bib-0073){ref-type="ref"}
  ClpP/R protease complex             *A. thaliana*                     Clp3/4/5/6 (1:2:3:1) Clp1/ClpR1/2/3/4 (3:1:1:1:1)                       Affinity purification                  qConCAT                  Olinares et al. [74](#pmic8038-bib-0074){ref-type="ref"}
  Transducin complex                  Bovine (expressed in *E. coli*)   GABα/β/γ (1:1:1)                                                        Affinity purification (His tag)        qConCAT                  Nanavati et al. [75](#pmic8038-bib-0075){ref-type="ref"}
  Ribosome                            *E. coli*                         \>10 Subunits (diverse)                                                 Sucrose gradients                      qConCAT                  Al‐Majdoub et al. [76](#pmic8038-bib-0076){ref-type="ref"}
  eIF2B‐eIF2                          *S. cerevisiae*                   eIF2B(αβγδε)/eIF2(αβγ) (1:1:1:1:1)/(0.3:0.3:0.3)                        Tandem affinity purification           PCS                      Kito et al. [77](#pmic8038-bib-0077){ref-type="ref"}
  V1‐ATPase                           *S. cerevisiae*                   A/B/DE/FG/H (3:3:3:3:1)                                                 Immunopurification + SEC               ^15^N in vivo labeling   Kitagawa et al. [78](#pmic8038-bib-0078){ref-type="ref"}

John Wiley & Sons, Ltd.

An alternative to the SRM approach is to use integrated extracted ion chromatograms generated from data‐dependent acquisition LC‐MS/MS experiments, as exemplified by the intensity‐based absolute quantification (iBAQ) approach that we discuss later. While these are readily available from protein identification experiments without further optimization, quantitation from extracted ion chromatograms often suffers from the intrinsically higher background in the MS domain and inconsistent numbers of data points generated across chromatography peaks, resulting in increased variation of quantitation values.

An intrinsic (i.e. mass‐spectrometric) limitation of the peptide‐based MS approach is encountered in the determination of high stoichiometric ratios (\>10:1). As the SD of the concentration measurements is usually in the range of 10%, above a ratio of 1:10 biologically meaningful but inaccurate stoichiometries might be found within the SD [38](#pmic8038-bib-0038){ref-type="ref"}. Intriguingly, most of the stoichiometries determined by MS so far show low ratios or even equimolarity of the constituents (Table [2](#pmic8038-tbl-0002){ref-type="table-wrap"}). Another limitation of the peptide‐based approach arises when heterogeneous populations are investigated. Proteolysis of heterogeneous complex preparations results in the measurement of averaged stoichiometries, obscuring the intrinsic stoichiometries of the single complexes. In contrast to native MS, which is able to deconvolute and even to resolve the dynamics of different coexisting complex populations [79](#pmic8038-bib-0079){ref-type="ref"}, [80](#pmic8038-bib-0080){ref-type="ref"}, this information is lost upon proteolysis. Consequently, great care should be taken to assay and monitor the purity and integrity of the complex where possible, and to differentiate between stable and dynamic constituents (see above). However, the presence of heterogeneous complex populations in a sample is never beneficial in an investigation of complexes using any of the approaches discussed.

Peptide‐based methods compensate for the above‐mentioned restrictions by being far more tolerant than MS of intact protein complexes toward different buffer compositions or sample impurities. For sample preparation, all buffers, salts, crowding agents, and detergents that are necessary to stabilize the complex can be used during purification. However, observed stoichiometry values can be dependent on the protocol used to solubilize and proteolyze a given complex [64](#pmic8038-bib-0064){ref-type="ref"}, which highlights the necessity of protocol optimization. Moreover, as in particular SRM‐based methods are highly selective and sensitive and can even quantify low‐abundance proteins in lysates [81](#pmic8038-bib-0081){ref-type="ref"}, stoichiometries can be determined in complex samples and the only requirement is that unbound ligands be removed before proteolysis. Another benefit is that once a targeted peptide‐based (SRM) assay has been established, it can also be used to quantify the expression level of the proteins involved in complex formation, to correlate the stoichiometry with the concentration of any other protein or PTM [73](#pmic8038-bib-0073){ref-type="ref"} in the sample and to track complex disintegration [68](#pmic8038-bib-0068){ref-type="ref"} or sample losses at different stages of the purification process. For a more detailed description of the SRM method, we refer to excellent reviews [82](#pmic8038-bib-0082){ref-type="ref"}, [83](#pmic8038-bib-0083){ref-type="ref"}, [84](#pmic8038-bib-0084){ref-type="ref"}.

Of late, there have been attempts to replace the highly targeted MS approach to quantification by more generic label‐free techniques that use generic protein standards, standards that can be applied to any study without prior optimization. Selbach and co‐workers have recently introduced the iBAQ [85](#pmic8038-bib-0085){ref-type="ref"} approach. In brief, the intensities for all observed tryptic peptides assigned to a protein are summed and scaled relative to the number of peptides that can theoretically be generated for this protein by tryptic cleavage. The resulting iBAQ values are generated for all proteins in a sample from regular nontargeted data acquisition, without protein‐ or peptide‐specific optimization. Absolute quantification (i.e. determination of concentrations or copy numbers of the proteins in the sample) is achieved by spiking the sample with a generic protein standard spanning a large dynamic range in terms of molecular weight and molarity, such as the commercially available Universal Proteomics Standard 2. The data are then calibrated with the iBAQ values for the standard proteins at their known concentrations. iBAQ and the related Protein Abundance Index method have been used to determine the stoichiometries of several protein complexes [86](#pmic8038-bib-0086){ref-type="ref"}, [87](#pmic8038-bib-0087){ref-type="ref"}, [88](#pmic8038-bib-0088){ref-type="ref"}, including the human hPrp19/CDc5L spliceosomal complex [89](#pmic8038-bib-0089){ref-type="ref"}. A comparison with previously published data using targeted SRM quantification with tailored synthetic peptide standards [64](#pmic8038-bib-0064){ref-type="ref"} showed overall good agreement between the stoichiometric values obtained. However, small ratio changes---such as the difference between 1:3 and 1:2---were difficult to determine in the published data, leaving a question mark against the accuracy of the approach. Furthermore, iBAQ works best when proteins of similar size are analyzed. Small and basic proteins such as those often found in protein--RNA complexes often lead to deviating stoichiometry values as exemplified for the ribosomal proteins [90](#pmic8038-bib-0090){ref-type="ref"}. To overcome these limitations, Limbach et al. combined iBAQ with multiple enzymatic digestions and ion mobility separation [91](#pmic8038-bib-0091){ref-type="ref"}. Despite these shortcomings, global label‐free quantification approaches such as iBAQ present a promising development, especially when used in combination with other non‐MS‐based methods or as a primary comparative screen, since they do not require significant prior optimization.

5. Critical steps in peptide‐based stoichiometry determination {#pmic8038-sec-0050}
==============================================================

5.1. Reference peptide generation with available technical platforms {#pmic8038-sec-0060}
--------------------------------------------------------------------

As outlined above, the generation of proxy peptides is a prerequisite for the peptide‐based approach using reference peptides. Various technological platforms have been developed and applied for the generation of reference peptides for targeted peptide‐based quantification assays. They differ mainly in the source of the reference peptides and---in relation to this---the time point of their addition during the sample preparation workflow (Table [3](#pmic8038-tbl-0003){ref-type="table-wrap"}) [63](#pmic8038-bib-0063){ref-type="ref"}, [70](#pmic8038-bib-0070){ref-type="ref"}, [72](#pmic8038-bib-0072){ref-type="ref"}, [77](#pmic8038-bib-0077){ref-type="ref"}, [92](#pmic8038-bib-0092){ref-type="ref"}, [93](#pmic8038-bib-0093){ref-type="ref"}, [94](#pmic8038-bib-0094){ref-type="ref"}, [95](#pmic8038-bib-0095){ref-type="ref"}, [96](#pmic8038-bib-0096){ref-type="ref"}, [97](#pmic8038-bib-0097){ref-type="ref"}, [98](#pmic8038-bib-0098){ref-type="ref"}, [99](#pmic8038-bib-0099){ref-type="ref"}.

###### 

Different strategies for the addition of reference peptides

  Source of the peptide   Level of labeling                                                                        Type of label                                              Method of quantification                                                                                                              Abbreviation                                          References
  ----------------------- ---------------------------------------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------
  Reference peptide       Chemical synthesis using labeled amino acids                                             Heavy isotope labeled amino acids                          Amino acid analysis Frank et al. [100](#pmic8038-bib-0100){ref-type="ref"}, Arsene et al. [142](#pmic8038-bib-0142){ref-type="ref"}   AQUA (absolute quantification)                        Gerber et al. [63](#pmic8038-bib-0063){ref-type="ref"}
                          Chemical postsynthesis tagging                                                           Isotope‐labeled tags                                       Weighing                                                                                                                              ICPL                                                  Hochleitner et al. [70](#pmic8038-bib-0070){ref-type="ref"}
  Reference concatamer    Metabolic labeling                                                                       ^15^N label                                                Not necessary for stoichiometries                                                                                                     QconCAT                                               Beynon et al. [92](#pmic8038-bib-0092){ref-type="ref"}
                          Enzymatic labeling in vivo                                                               Heavy isotope labeled amino acids                          Not necessary for stoichiometries                                                                                                     PCS (peptide concatenated standard)                   Kito et al. [77](#pmic8038-bib-0077){ref-type="ref"}
                          In vitro translation incorporating labeled amino acids                                   Heavy isotope labeled amino acids: K                       Not necessary for stoichiometries                                                                                                     polySIS                                               Anderson et al. [93](#pmic8038-bib-0093){ref-type="ref"}
                          Chemical synthesis, trypsination, labeling                                               mTRaq                                                      Equalization using a concatenated reporter peptide                                                                                    EtEP (equimolarity through equalizer peptide)         Holzmann et al. [72](#pmic8038-bib-0072){ref-type="ref"}
  Reference protein       In vitro translation (*E. coli* extract) incorporating labeled amino acids               Heavy isotope labeled amino acids: R/K                     Amino acid analysis                                                                                                                   PSAQ (protein standard for absolute quantification)   Brun et al. [94](#pmic8038-bib-0094){ref-type="ref"} Protein synthesis: Torizawa et al. [95](#pmic8038-bib-0095){ref-type="ref"}
                          In vitro translation (wheat germ extract) incorporating labeled amino acids              Heavy isotope labeled amino acids: R/K                     Quantification of a tag peptide after digestion using the AQUA approach                                                               Flexiquant                                            Singh et al. [96](#pmic8038-bib-0096){ref-type="ref"} Protein synthesis: Endo and Sawasaki [97](#pmic8038-bib-0097){ref-type="ref"}
                          In vitro translation *(E. coli* extract) incorporating labeled amino acids               Heavy isotope labeled amino acids: R/K+ selenomethionine   ICPMS quantification of selenomethionine                                                                                              RISQ                                                  Zinn et al. [98](#pmic8038-bib-0098){ref-type="ref"}
                          Metabolic labeling in vivo (auxotrophic *E. coli* strain) or upon in vitro translation   Heavy isotope labeled amino acids: R/K                     Amino acid analysis                                                                                                                   Absolute SILAC                                        Hanke et al. [99](#pmic8038-bib-0099){ref-type="ref"}

John Wiley & Sons, Ltd.

First, reference peptides can be synthesized chemically and added to the sample before or after digestion. Gygi and colleagues refined this method and termed it AQUA [63](#pmic8038-bib-0063){ref-type="ref"}. The clear advantage of this strategy is that it is very flexible, as AQUA peptides for different target proteins can be combined freely. Since isotopic labeling occurs upon chemical synthesis, the position and type of label can be freely chosen. In addition, isotopically labeled versions of, for example, post‐translationally modified peptides can be synthesized and quantified along with unmodified peptides. As for any other standards, quantification using AQUA peptides is only as accurate as the determination of concentrations of synthetic peptides. Amino acid analysis [100](#pmic8038-bib-0100){ref-type="ref"} is still considered the gold standard for the quantification of peptides; unlike, for example, UV‐ or fluorescence‐based methods, it does not depend on specific sequence features. However, it requires relatively large amounts of peptide compared with MS and is costly to perform for large numbers of peptides. Owing to the high cost of peptide synthesis and peptide quantification, candidate sequences for AQUA peptides have to be selected carefully, and digestion efficiency and peptide stability have to be monitored thoroughly, as will be described in the last part of this review. In addition, AQUA peptides are added late in the overall workflow (Table [3](#pmic8038-tbl-0003){ref-type="table-wrap"}), with the consequence that possible analyte losses incurred by sample processing [94](#pmic8038-bib-0094){ref-type="ref"} or adsorption cannot be corrected. For the determination of protein stoichiometry, however, relative quantification is sufficient, as only the ratios between the complex constituents' concentrations are determined. Provided that the complex stoichiometry is conserved throughout sample preparation, overall losses in the total complex abundance are not necessarily problematic per se.

Alternatively, selected peptide proxies for different proteins can be concatenated into a single artificial gene that is then translated in vivo or in vitro into an artificial protein in an approach termed QconCAT (quantification concatamer, Table [3](#pmic8038-tbl-0003){ref-type="table-wrap"} [92](#pmic8038-bib-0092){ref-type="ref"}). In contrast to individual reference peptides, concatamer proteins have to be added before the digestion step. Because they do not share the tertiary structure of the target proteins, they do not allow classical prefractionation at the protein level [94](#pmic8038-bib-0094){ref-type="ref"}. Following digestion, however, enrichment by classical chromatographic methods or IEF [101](#pmic8038-bib-0101){ref-type="ref"} is possible, in the same way as for individual reference peptides. Ideally, all the encoded reference peptides will be formed in an equimolar ratio upon enzymatic digestion of the concatamer. For complex stoichiometry determinations, this equimolarity is especially useful, because an absolute concentration is not needed and it allows an easy and precise determination of stoichiometry. However, because of the equimolarity of the reference peptides generated, no copy numbers of proteins in a complex can be determined unless the total amounts of both the intact complex and the concatamer are known. While both AQUA peptides and concatamers rely on the complete formation of the endogenous peptides (see also above), other sources of error are orthogonal. Although the accuracy of the AQUA strategy relies on the accuracy of the AQUA peptide concentration determination and the precision of pipetting and peptide handling, the concatamer strategy depends on the quantitative digestion of the concatamer [102](#pmic8038-bib-0102){ref-type="ref"}. As concatamers do not share the higher order structure of the endogenous proteins, their digestion kinetics will often be different, in most cases faster, because of the lack of a stable fold [103](#pmic8038-bib-0103){ref-type="ref"}. An interesting intermediate between the AQUA and QconCAT strategies is the EtEP (equimolarity through equalizer peptide [72](#pmic8038-bib-0072){ref-type="ref"}) approach. This is based on sets of tryptic reference peptides that are all fused to the same equalizer peptide. Following tryptic digestion, the equalizer peptide\'s concentrations are determined by targeted MS, and by using these EtEP concentrations one can correct all EtEP reference peptides to equimolarity. Thereafter, differential isotopic labeling with a nonisobaric chemical label can be used to differentiate the native and reference peptides, making the EtEP approach a very cost‐efficient alternative to direct synthesis and quantification of AQUA peptides, especially for larger assays requiring numerous reference peptides. Alternatively, tandem peptides [104](#pmic8038-bib-0104){ref-type="ref"} (representing the minimal QconCAT) can be used for stoichiometry determination. Tandem peptides comprising two target peptide sequences from two subunits are optimal for ensuring equimolarity after proteolysis. This approach, which has not been widely applied so far, should work mainly for small complexes because for larger complexes it leads to a combinatorical explosion of tandem peptides needed.

While all these reference peptide strategies rely on the correct preselection of proxy reference peptides (see last section), the use of entire isotopically labeled reference proteins instead of only peptides makes this limitation irrelevant because all possible peptides from a protein can be studied at once. Isotopically labeled reference proteins can be translated in vitro or in vivo. Translation in vitro is restricted to some model translation systems such as wheat germ extract [105](#pmic8038-bib-0105){ref-type="ref"}, rabbit reticulocyte [106](#pmic8038-bib-0106){ref-type="ref"}, human HeLa [107](#pmic8038-bib-0107){ref-type="ref"}, or S30 *Escherichia coli* lysates, or the reconstituted *E. coli* translation system [108](#pmic8038-bib-0108){ref-type="ref"}; nevertheless, it has the advantage that the synthesis can easily be manipulated, for example, for labeling with isotopically labeled amino acids. Alternatively, reference proteins prepared by translation in vivo might also contain PTMs if a eukaryotic expression system is chosen. Isotope labeling of proteins biosynthesized in vivo can be performed either metabolically (e.g. by ^15^N labeling; [109](#pmic8038-bib-0109){ref-type="ref"}), or more elegantly by supplying isotopically labeled amino acids to auxotrophic strains that are only available for selected organisms [99](#pmic8038-bib-0099){ref-type="ref"}, [110](#pmic8038-bib-0110){ref-type="ref"}. In addition, reference proteins can be labeled isotopically ex vivo by any chemical labeling following synthesis and purification (Table [3](#pmic8038-tbl-0003){ref-type="table-wrap"}). In general, reference proteins have the advantage that they can be added upstream in the sample preparation workflow, as they are nearly identical to the endogenous target protein. Brun et al. showed that this indeed corrects for analyte losses upon purification and leads to higher measured protein concentrations compared with the AQUA or QconCAT strategy [94](#pmic8038-bib-0094){ref-type="ref"}. Although such reference proteins should in principle exhibit the same digestion kinetics upon treatment with endoproteinase as their endogenous counterparts, this need not always be the case. A protein might exhibit different proteolysis kinetics in the free and complexed states. Also, proteins in native complexes---that is those isolated directly from cells---might behave differently from overexpressed ones. Many overexpressed proteins tend to be incorrectly folded, especially when expressed heterologously. Proper folding is often coupled to the finely tuned rate of protein synthesis, which is known to be organism‐specific [111](#pmic8038-bib-0111){ref-type="ref"}, [112](#pmic8038-bib-0112){ref-type="ref"}, [113](#pmic8038-bib-0113){ref-type="ref"}. In addition, PTMs have been found to affect folding [114](#pmic8038-bib-0114){ref-type="ref"}.

5.2. Peptide selection, peptide stability, and peptide formation {#pmic8038-sec-0070}
----------------------------------------------------------------

The fact that proteins are quantified via peptides---or, more generally, that the internal standard differs from the actual analyte in its unprocessed state---makes high demands on the selection of proper proxy peptides and sample treatment. Under these circumstances, acquiring more than one experimental value for a protein\'s concentration greatly increases the robustness of the method. As a rule of thumb, for accurate determination of protein stoichiometries and copy numbers, at least three proxy peptides per protein should be selected and used as reference peptides. This poses a challenge in particular where smaller, basic, or largely hydrophobic proteins are investigated---for example RNA‐binding or membrane proteins that contain only a limited number of suitable proxy peptides. In addition, the choice of adequate proxy peptides has to follow certain rules of peptide biochemistry (see below, Fig. [3](#pmic8038-fig-0003){ref-type="fig"})

![The use of time courses in evaluating the quantification accuracy. (A) Tracking the missed cleaved peptides over time helps to evaluate the completeness of the digestion with respect to the selected peptides. (B) In the case of unstable peptides even at the maximum, the signal intensity does not reflect the level of endogenous peptides. (C) When slow forming and unstable peptides are combined, there is no time point at which the integrated area ratio reflects the true stoichiometry. (D) When stable peptides are inspected, the time point of AQUA peptide addition does influence the observed stoichiometry, which equals the true stoichiometry. (E) Degradation reactions that have the same rate in the peptide and protein context decrease the observed stoichiometry when the AQUA peptide is added after the digestion. The true stoichiometry can be assessed when the AQUA peptide is added early in the workflow. (F) Degradation reactions that have faster rate or only occur in the peptide context lead to wrong stoichiometries irrespective of the time point of AQUA peptide addition. Notably, the addition prior or upon digestion will mask this problem since a stable stoichiometry is observed. To detect such degradation reaction, the addition after digestion is much more indicative.](PMIC-15-862-g003){#pmic8038-fig-0003}

Clearly, proxy peptides should exhibit suitable properties for MS analysis and represent unambiguously the protein of interest; these two properties were summed up as the property of "proteotypicity" [115](#pmic8038-bib-0115){ref-type="ref"}. Candidate peptides can be selected from databases such as the PeptideAtlas ([www.peptideatlas.org/](http://www.peptideatlas.org/)), PRIDE ([www.ebi.ac.uk/pride/](http://www.ebi.ac.uk/pride/)), Human Proteinpedia ([www.humanproteinpedia.org](http://www.humanproteinpedia.org)), and the Global Proteome Machine (<http://gpmdb.thegpm.org/>), which contain sets of tryptic peptides that are frequently observed in global proteomics experiments. As the peptide sets contained in these repositories were generated by analyzing very different sample types on different MS platforms, experimental determination of suitable peptides should always supersede, or at least complement, simple selection from databases. Peptides are only proteotypic when they are unique to that protein against the sample\'s background, so that following digestion the concentration of the peptide as determined equals that of the protein. Proteotypic peptides can be either computationally predicted by algorithms trained on large datasets [115](#pmic8038-bib-0115){ref-type="ref"}, [116](#pmic8038-bib-0116){ref-type="ref"}, [117](#pmic8038-bib-0117){ref-type="ref"} or else chosen from available databases [84](#pmic8038-bib-0084){ref-type="ref"}, [118](#pmic8038-bib-0118){ref-type="ref"}. However, Jaquinod et al. have shown that predictions of the best reference peptides for a particular protein show poor [119](#pmic8038-bib-0119){ref-type="ref"} or even no [81](#pmic8038-bib-0081){ref-type="ref"} correlation with experimental data. In contrast to the multitude of proteins in shotgun MS proteomic experiments, the set of proteins in a macromolecular complex of interest is small, which makes the experimental inspection of all possible peptides a viable alternative in many cases [82](#pmic8038-bib-0082){ref-type="ref"}.

The central assumption that the protein concentration equals the concentration of a reference peptide is, furthermore, only valid when the proteotypic peptides are quantitatively formed from the endogenous protein upon proteolysis [120](#pmic8038-bib-0120){ref-type="ref"} and do not decay over time. Beynon and colleagues termed such peptides that are not only proteotypic but also well suited to represent the protein concentration "quantotypic" [121](#pmic8038-bib-0121){ref-type="ref"}. These criteria make even higher demands on the selection of the reference peptides and on the digestion conditions [64](#pmic8038-bib-0064){ref-type="ref"}, [122](#pmic8038-bib-0122){ref-type="ref"} and have prompted us to discuss tryptic proteolysis in combination with peptide stability consideration in detail.

In the initial phase of proteolytic digestion, organic solvents, chaotropes, and surfactants can help to destabilize the protein structure and thereby improve the susceptibility toward protease cleavage. In this phase, the efficiency of cleavage depends mainly on the specific folds of the respective proteins [123](#pmic8038-bib-0123){ref-type="ref"}, [124](#pmic8038-bib-0124){ref-type="ref"} and their tendency to unfold, on the solubility of the proteins, and on the presence of stabilizing disulfide bridges. As these properties can vary between individual domains in a protein, it is recommended that peptides from different regions of the target protein be quantified separately and the results consolidated.

After the first phase of proteolysis, the speed and completeness of the digestion depend mainly on the local sequence contexts of the scissile bonds. In the case of trypsin, two sources of incomplete digestion can be distinguished. First, dead‐end products can be formed when the product peptides have bibasic sequences (XXXXBB) or dipeptidyl extensions (XXXXBXB), because trypsin has only weak exonuclease activity even for cationic amino acid residues. The second source of incomplete digestion is the fact that even when complete digestion is possible, the rate is strongly influenced by at least the three neighboring residues. Especially, aspartate and glutamate residues can form salt bridges with the lysines and arginines of the tryptic binding sites, and these bridges decelerate the tryptic digestion. Unfortunately, Asp and Glu also increase the detectability of peptides, so that Asp/Glu‐containing peptides are actually overrepresented in proteotypic peptides [115](#pmic8038-bib-0115){ref-type="ref"}. The propensities of other amino acid residues are less pronounced and harder to rationalize, but new software algorithms trained on large peptide datasets can help to predict peptides with efficient cleavage sites [125](#pmic8038-bib-0125){ref-type="ref"}, [126](#pmic8038-bib-0126){ref-type="ref"}. When no optimal peptides are available in a given target protein, prolonged digestion times and higher concentrations of protease and/or substrate [127](#pmic8038-bib-0127){ref-type="ref"} are necessary in order to complete the digestion. Alternatively, tandem LysC/trypsin proteolysis protocols have shown a superior cleavage efficiency when compared with trypsin alone [128](#pmic8038-bib-0128){ref-type="ref"}. In addition, elevated temperatures, immobilized trypsin, ultrasonication, high pressure, microwave energy, and microreactors have been shown to speed up proteolysis (reviewed in [129](#pmic8038-bib-0129){ref-type="ref"}, [130](#pmic8038-bib-0130){ref-type="ref"}).

Digestion protocols have to be optimized for every individual complex [120](#pmic8038-bib-0120){ref-type="ref"}. For example, Schmidt et al. [64](#pmic8038-bib-0064){ref-type="ref"} demonstrated that the observed stoichiometric ratios for the human spliceosomal hPrp19/CDC5L complex were directly dependent on the protocol used for solubilization and digestion of the complex. To this end, digestion efficiency should be assessed and monitored at different stages. At the protein level, uncleaved proteins can be tracked over time by SDS‐PAGE, or after chromatographic separation by UV/VIS spectroscopy or MS [131](#pmic8038-bib-0131){ref-type="ref"}. At the peptide level, the MS results yield the average charge states of all peptides, the overall number of identified spectra [132](#pmic8038-bib-0132){ref-type="ref"}, [133](#pmic8038-bib-0133){ref-type="ref"}, the relative amount of missed cleavage peptides, and the sequence coverage. As these features characterize the overall, global digestion efficiency rather than providing information about the formation of an individual target peptide, it is recommended that one complements the global analysis by monitoring the time courses of formation of the target peptides, for example by SRM. Often it is informative to track possible missed cleaved peptides and thus precursors of the target peptide simultaneously (Fig. [3](#pmic8038-fig-0003){ref-type="fig"}A [120](#pmic8038-bib-0120){ref-type="ref"}, [121](#pmic8038-bib-0121){ref-type="ref"}).

In addition to being formed quantitatively, peptides should also be stable in solution throughout the course of the analysis in order to represent the target protein properly. They should be resistant to chemical degradation processes such as oxidation, deamidation, or autocleavage (reviewed by Manning et al. [134](#pmic8038-bib-0134){ref-type="ref"}). In addition to chemical degradation processes, peptides can be physically lost owing to adsorption effects that are strongly surface‐ and peptide‐dependent [135](#pmic8038-bib-0135){ref-type="ref"} and can become dominant especially for hydrophobic peptides [136](#pmic8038-bib-0136){ref-type="ref"}. In order to avoid adsorption effects, peptide solutions should be handled and stored in as concentrated a form as possible [137](#pmic8038-bib-0137){ref-type="ref"}, in glass‐ or plastic ware optimized for this [135](#pmic8038-bib-0135){ref-type="ref"}. In addition, carrier proteins can be used to minimize adsorption, especially at low peptide concentrations. To avoid selecting peptides that are prone to such degradation or adsorption, useful heuristic rules for the selection of peptides have been formulated [83](#pmic8038-bib-0083){ref-type="ref"}.

In addition to these sequence‐dependent degradation processes, a peptide can be degraded by atryptic cleavage [84](#pmic8038-bib-0084){ref-type="ref"}, [138](#pmic8038-bib-0138){ref-type="ref"}, by unspecific labeling with iodoacetamide (which is often used to derivatize cysteines) [139](#pmic8038-bib-0139){ref-type="ref"}, [140](#pmic8038-bib-0140){ref-type="ref"}, or by the reaction with isocyanates [140](#pmic8038-bib-0140){ref-type="ref"}, [141](#pmic8038-bib-0141){ref-type="ref"} that are present as an impurity when urea is used as a chaotrope. Because degradation processes are time‐dependent, the amount of peptides found is determined by the completeness of digestion and thus formation of the target peptide on the one hand, and potential degradation processes that remove the target peptide on the other (Fig. [3](#pmic8038-fig-0003){ref-type="fig"}B and C). In such cases, even the highest peptide concentration attained does not reflect the theoretical protein concentration. Especially, when slow‐forming and chemically unstable peptides are combined, it is obvious (Fig. [3](#pmic8038-fig-0003){ref-type="fig"}C) that stoichiometries cannot be correctly quantified because the available peptide concentration is strongly time‐dependent. To exclude such scenarios, it is again valuable to choose reference peptides on the basis of experimentally observed digestion kinetics. Peptides that reach a plateau and do not decay are obviously stable (Fig. [3](#pmic8038-fig-0003){ref-type="fig"}D). Because the reference peptide has the same physicochemical properties as the endogenous tryptic peptide, it can be expected that it will undergo the same decomposition reactions and at the same speed. In practice, it is often recommended that the reference peptide be added as early as possible in the quantification workflow, in order to improve correction for physical loss or degradation (Fig. [3](#pmic8038-fig-0003){ref-type="fig"}E). The correction by early addition works only if the endogenous proxy peptide has the same propensity toward loss or degradation in solution compared with its corresponding propensity when still in the macromolecular environment of the protein.

For a number of degradation events, such as N‐terminal cyclization, deamidation, or backbone cleavage, it is known that their kinetics depend on the higher order structure of the peptide in the protein (or in larger fragments derived from the protein) [134](#pmic8038-bib-0134){ref-type="ref"}. In such cases, a corresponding reference peptide will be degraded much more rapidly than the endogenous peptide in the initial phase of digestion, as the latter is still shielded by its protein environment (Fig. [3](#pmic8038-fig-0003){ref-type="fig"}F). In these cases, the amount of the endogenous peptide will therefore be overestimated, even though the time course of the stoichiometry does not necessarily reveal any degradative path. The extent of this effect depends on differences in degradation kinetics between protein and peptide and on the speed of digestion. Slower digestions will lead to larger overestimations than faster digestions [142](#pmic8038-bib-0142){ref-type="ref"}, highlighting the importance of selecting stable reference peptides and of optimizing the conditions of digestion. In such a scenario, there is no ideal time point to add reference peptides, since concurrent and postdigestion addition both lead to incorrect stoichiometries. To exclude such scenarios, it is thus advisable to compare the stoichiometry with the pre‐ and postdigestion addition of AQUA peptides, or at least to track the endogenous peptide over time. If stable peptides cannot be found, then such degradation processes may be corrected for by kinetic modeling; otherwise, a different reference source must be used, one that resembles the endogenous protein more closely, throughout the analytical process [143](#pmic8038-bib-0143){ref-type="ref"}.

Concatenated peptides as sources of reference proxy peptides do not share the tertiary structure of the target protein and thus have different digestion kinetics [103](#pmic8038-bib-0103){ref-type="ref"}. In order to attain comparable cleavage efficiencies, Kito et al. included the flanking sequences of the individual concatenation peptides in the QconCAT design [77](#pmic8038-bib-0077){ref-type="ref"}. Along the same lines, Barnidge et al. [144](#pmic8038-bib-0144){ref-type="ref"} investigated the use of cleavable reference peptides in order to retain the flexibility of reference peptides compared with the QconCAT approach. However, it is still unlikely that all the approaches and corrections mentioned here adequately correct for all the kinetics of peptide formation and decay. Therefore, reference proteins (Table [3](#pmic8038-tbl-0003){ref-type="table-wrap"}) have become the gold standard because they share the same amino acid sequence and secondary and tertiary structures with the endogenous protein, albeit with the exceptions mentioned above. Consistently, Jaquinod et al. showed that with the use of reference proteins even noncanonical reference peptides (containing Met/Cys‐ or missed cleavage sites) can be successfully employed for absolute quantification [119](#pmic8038-bib-0119){ref-type="ref"}.

Since protein concentration determinations are error‐prone per se, concatenated proteins or subunits could offer an attractive technical solution They share the advantage of the QconCAT strategy that guarantees theoretical equimolarity of reference peptides; in addition, they have higher order structures similar to those of the endogenous proteins, which helps to correct for differential digestion rates and thus extends the set of potential reference sequences [119](#pmic8038-bib-0119){ref-type="ref"}. Comparable approaches were first applied by Isacoff and colleagues [145](#pmic8038-bib-0145){ref-type="ref"}, who concatenated subunits of the voltage‐gated K^+^‐channel family to study the subunit stoichiometry and topology of receptors and ion channels (reviewed in [146](#pmic8038-bib-0146){ref-type="ref"}). In the meantime, various validation methods to ensure the uniformity and stoichiometry of expressed protein concatamers have emerged [147](#pmic8038-bib-0147){ref-type="ref"}. Combined with the technical progress in rapid and cost‐efficient synthesis of artificial genes, this technique could become an improved platform in cases of small‐ to medium‐sized complexes when highly accurate stoichiometry values are required.

6. Summary {#pmic8038-sec-0080}
==========

Accurate and precise determination of protein stoichiometry in protein complexes remains challenging. However, the development of mass‐spectrometric technologies and their continuous improvement, together with the establishment of corresponding workflows for the introduction of quantitative standards, are beginning to allow the elucidation of protein stoichiometries in a much more precise manner than classical methods have done. Both of the MS‐based approaches---MS of intact protein complexes and the peptide‐based MS methodology---have proven their value in an increasing number of studies.

Peptide‐based MS can be easily implemented into any mass spectrometric based proteomic workflow for the following reasons: First, it is highly sensitive. Second, it is tolerant to different detergents and salts; this makes it largely orthogonal to other approaches. Third, the analytical workflow is straightforward, as it can be performed with almost any ESI‐MS. Fourth, data evaluation is also straightforward and dedicated software tools including tutorials are freely available (e.g. Skyline [148](#pmic8038-bib-0148){ref-type="ref"}). Finally, peptide‐based MS allows the co‐quantification of protein expression levels, free ligand concentrations, PTMs, sample loss, and even whole signal cascades.

Special consideration has to be given to the question of how reference proxy peptides for such analyses are to be predicted and subsequently generated. Several approaches have emerged, each with specific advantages: global protein standards for label‐free MS such as iBAQ for comparative screening of stoichiometry values and/or determination of protein copy numbers in highly complex samples; AQUA strategies for highly flexible and accurate applications; concatamers for handling large numbers of samples in parallel, from, for example, cellular pathways; and reference proteins (or even concatenated proteins) for high‐precision quantification relying on a larger set of proxy peptides.

In addition, it is worthwhile to consider the interconnected issues of sample preparation, peptide selection, peptide stability, and especially protein digestion. Here, a deeper understanding and the optimization of protocols can help to identify optimum reference peptides and digestion conditions. In this context, the study of time courses appears to be particularly useful.
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